Lofexidine is an α2A adrenergic receptor agonist, historically used as an
antihypertensive, but more commonly used to alleviate the physical symptoms of
Lofexidine tablets are used to replace opiates when the usage of opiods is trying
to be reduced.
Lofexidine is approved in the United Kingdom as BritLofex<sup>®</sup> and has been used
in successful detoxification of more than 200,000 opiate addicts. US WorldMeds ...
Lofexidine (Subutex, Buprenorphine, Britoflex, Naltraxone). Lofexidine
SCIENTIFIC TERM: 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-
May 3, 2016 ... Review question. We reviewed the evidence about the effect of alpha2-
adrenergic agonists (clonidine, lofexidine, guanfacine, and tizanidine) ...
Guidance For The Use Of Lofexidine In The Symptomatic Management. Of Opioid
Withdrawal By Clinicians Working Within NHS Grampian. Co-ordinators:.
Oct 8, 2015 ... The dosage of lofexidine should be titrated according to the patient's response.
Initial dosage should be 0.8mg per day in divided doses.
The objective of this article was to review the data from recently published trials of
lofexidine in the treatment of opiate withdrawal, with particular attention to ...
What is Lofexidine? Lofexidine is prescribed to reduce the symptoms of
withdrawal from opiate addiction during supervised detoxification. The drug acts